Jangus Whitner
Healthcare Policy & Compliance | Board Member | Patient Advocate | 340B ACE | BCACP
- Role
- Member, Board of Trustees at Neighborhood Health Association
- Location
- Toledo, OH, US
- LinkedIn followers
- 500 followers
About Jangus Whitner
Currently working in Healthcare and Drug Pricing Policy & Compliance as a Director for Apexus, HRSA\'s Prime Vendor for its federal 340B Drug Pricing Program. Previously a Director of Pharmacy Services for a large federally qualified health center. I am. PASSIONATE about care for vulnerable patients, equitable health policy initiatives, pharmacy law, community outreach, and public health PGY2 TRAINED with a focus in primary care for underserved patient populations DIPLOMAT of American Society of Pharmacy Law (DASPL): completed the one-year pharmacy law leadership program for mid-career professionals EXCITED that I get to wake up everyday to work within the 340B Program that does so much for the nation\'s underserved and indigent patients You\'ve probably guessed, but yes I am a big #340B nerd. Excited at any opportunity to talk about the positive impact of the 340B program!#340BACE #pharmacylaw
Experience
Member, Board of Trustees
Neighborhood Health Association
Feb 2025 — Present · Toledo, OH, US
Education
University of Toledo
Bachelor of Science & Pharmaceutical Sciences (BSPS)
2010
Franklin University
Master of Healthcare Administration (MHA)
University of Toledo College of Pharmacy and Pharmaceutical Sciences
Doctor of Pharmacy (PharmD)
Universidad Autónoma de Guadalajara
Intensive Medical Spanish for Healthcare Professionals; Guadalajara, Mexico.
HarvardX
U.S. Government X-Series Certificate Program
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.